{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:14:43Z","timestamp":1761513283386},"reference-count":13,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.vaccine.2013.03.050","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T03:49:38Z","timestamp":1366170578000},"page":"2719-2722","source":"Crossref","is-referenced-by-count":19,"title":["Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers"],"prefix":"10.1016","volume":"31","author":[{"given":"Prasad S.","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amita","family":"Sapru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep M.","family":"D\u2019costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shampur N.","family":"Madhusudana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwin Belludi","family":"Yajaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somnath","family":"Mangrule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagwat","family":"Gunale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish R.","family":"Bavdekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2013.03.050_bib0005","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2013.03.050_bib0010","unstructured":"WHO. Expert consultation on rabies: first report. Geneva, World Health Organization, 2005 (WHO Technical Report Series, No. 931; http:\/\/whqlibdoc.who.int\/trs\/WHO_TRS_931_eng.pdf)."},{"issue":"32","key":"10.1016\/j.vaccine.2013.03.050_bib0015","first-page":"309","article-title":"WHO position paper","volume":"85","author":"Rabies Vaccines","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2013.03.050_bib0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2005.10.007","article-title":"Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey","volume":"11","author":"Sudarshan","year":"2007","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2013.03.050_bib0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/oxfordjournals.aje.a121323","article-title":"Vaccine production in human diploid cell strains","volume":"94","author":"Plotkin","year":"1971","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2013.03.050_bib0030","first-page":"693","article-title":"Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine","volume":"78","author":"Briggs","year":"2000","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2013.03.050_bib0035","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2004.09.027","article-title":"Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals","volume":"23","author":"Quiambao","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.050_bib0040","unstructured":"http:\/\/www.who.int\/immunization_standards\/vaccine_quality\/Product_Insert_Rabipur_India_multilingual.pdf. [Accessed 09.07.12]."},{"key":"10.1016\/j.vaccine.2013.03.050_bib0045","unstructured":"http:\/\/www.who.int\/immunization_standards\/vaccine_quality\/Rabipur_Product_Insert.pdf. [Accessed 09.07.12]."},{"key":"10.1016\/j.vaccine.2013.03.050_bib0050","unstructured":"http:\/\/www.who.int\/immunization_standards\/vaccine_quality\/PQ_112_rabies_sanofi_PI_2010.pdf. [Accessed 09.07.12]."},{"key":"10.1016\/j.vaccine.2013.03.050_bib0055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0264-410X(89)90050-9","article-title":"Comparative study of the safety and protective value, in pre-exposure use, of rabies vaccine cultivated on human diploid cells (HDCV) and of the new vaccine grown on Vero cells","volume":"7","author":"Ajjan","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.050_bib0060","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0264-410X(89)90159-X","article-title":"Human diploid cell rabies vaccine purified by zonal centrifugation: a controlled study of antibody response and side-effects following primary and booster pre-exposure immunizations","volume":"7","author":"Fishbein","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.050_bib0065","first-page":"1102","article-title":"MR imaging in human rabies","volume":"24","author":"Laothamatas","year":"2003","journal-title":"Am J Neuroradiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13003964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13003964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T23:22:00Z","timestamp":1539732120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13003964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":13,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0264410X13003964"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.03.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}